233 related articles for article (PubMed ID: 24782188)
1. Long-term outcome of neuro-Behçet's disease.
Noel N; Bernard R; Wechsler B; Resche-Rigon M; Depaz R; Le Thi Huong Boutin D; Piette JC; Drier A; Dormont D; Cacoub P; Saadoun D
Arthritis Rheumatol; 2014 May; 66(5):1306-14. PubMed ID: 24782188
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
3. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
5. HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations.
Demirseren DD; Ceylan GG; Akoglu G; Emre S; Erten S; Arman A; Metin A
Genet Mol Res; 2014 Jul; 13(3):4788-96. PubMed ID: 25062414
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M
Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.
Xavier JM; Davatchi F; Abade O; Shahram F; Francisco V; Abdollahi BS; Trindade H; Nadji A; Shafiee NM; Ghaderibarmi F; Ligeiro D; Oliveira SA
Arthritis Res Ther; 2015 Mar; 17(1):81. PubMed ID: 25889189
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in Brazilian patients with Behçet's disease occurs independently of neurologic manifestation.
Dutra LA; de Souza AW; Alessi H; Guedes Bde V; Braga-Neto P; Pedroso JL; Gonçalves CR; da Rocha AJ; Bertolucci PH; Barsottini OG
J Neurol Sci; 2013 Apr; 327(1-2):1-5. PubMed ID: 23434335
[TBL] [Abstract][Full Text] [Related]
9. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
10. Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature.
Noel N; Hutié M; Wechsler B; Vignes S; Le Thi Huong-Boutin D; Amoura Z; Dormont D; Delcey V; Polivka M; Cacoub P; Saadoun D
Rheumatology (Oxford); 2012 Jul; 51(7):1216-25. PubMed ID: 22337940
[TBL] [Abstract][Full Text] [Related]
11. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.
Park KS; Ko HJ; Yoon CH; Park SH; Cho CS; Kim HY; Choe BY; Kim WU
Clin Exp Rheumatol; 2004; 22(5):561-7. PubMed ID: 15485008
[TBL] [Abstract][Full Text] [Related]
14. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management.
Al-Araji A; Kidd DP
Lancet Neurol; 2009 Feb; 8(2):192-204. PubMed ID: 19161910
[TBL] [Abstract][Full Text] [Related]
15. HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.
Pamukcu M; Duran TI; Demirag MD
J Coll Physicians Surg Pak; 2022 Jul; 32(7):904-908. PubMed ID: 35795941
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
Ishido T; Horita N; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Ishigatsubo Y; Takeno M; Kurosawa M; Kaneko T; Mizuki N
Rheumatology (Oxford); 2017 Nov; 56(11):1918-1927. PubMed ID: 28968732
[TBL] [Abstract][Full Text] [Related]
17. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease.
Kang EH; Park JW; Park C; Yu HG; Lee EB; Park MH; Song YW
Hum Immunol; 2013 Oct; 74(10):1363-7. PubMed ID: 23831258
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease.
Yan D; Liu J; Zhang Y; Yuan W; Xu Y; Shi J; Li C; Wang Y; Peng L; Yang Y; Zhou J; Wu D; Liu Z; Zeng X; Zhang F; Zheng W; Zhao Y
J Immunol Res; 2019; 2019():7371458. PubMed ID: 31612152
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
20. Mesencephalic form of meningoencephalitis in a patient with HLA-B51 Behçet's disease: case report.
Klissurski M; Milanov I; Stamenova P; Troyanova P; Vassileva E; Dulguerova P
Acta Clin Croat; 2011 Sep; 50(3):435-41. PubMed ID: 22384783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
